Cardiff Oncology Inc Share Price Today: Live Updates & Key Insights
Cardiff Oncology Inc share price today is $0.82, up -1.34%. The stock opened at $0.8375 against the previous close of $0.8381, with an intraday high of $0.8384 and low of $0.8.
Cardiff Oncology Inc Share Price Chart
Cardiff Oncology Inc
Cardiff Oncology Inc Share Price Performance
Cardiff Oncology Inc Institutional Holdings
Cardiff Oncology Inc Market Status
Cardiff Oncology Inc Fundamentals
Market Cap 65.20 M
PB Ratio 1.9282
PE Ratio 0.0
Enterprise Value 21.49 M
Total Assets 61.88 M
Volume 1200851
Cardiff Oncology Inc Company Financials
About Cardiff Oncology Inc & investment objective
Company Information Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 30
Industry Biotechnology
CEO Dr. Mani Mohindru Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Cardiff Oncology Inc FAQs
What is the share price of Cardiff Oncology Inc today?
The current share price of Cardiff Oncology Inc is $0.82.
Can I buy Cardiff Oncology Inc shares in India?
Yes, Indian investors can buy Cardiff Oncology Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Cardiff Oncology Inc shares in India?
You can easily invest in Cardiff Oncology Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Cardiff Oncology Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Cardiff Oncology Inc.
Can I buy fractional shares of Cardiff Oncology Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Cardiff Oncology Inc?
Cardiff Oncology Inc has a market cap of $65.20 M.
In which sector does Cardiff Oncology Inc belong?
Cardiff Oncology Inc operates in the Biotechnology sector.
What documents are required to invest in Cardiff Oncology Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Cardiff Oncology Inc?
The PE ratio of Cardiff Oncology Inc is N/A and the PB ratio is 1.93.